Asterisk Laboratories India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-11-2024
- Paid Up Capital ₹ 0.10 M
as on 17-11-2024
- Company Age 10 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.25 Cr
as on 17-11-2024
- Revenue -21.45%
(FY 2023)
- Profit -84.67%
(FY 2023)
- Ebitda -188.73%
(FY 2023)
- Net Worth 1.35%
(FY 2023)
- Total Assets 46.36%
(FY 2023)
About Asterisk Laboratories India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.25 Cr.
Ashwani Mehta and Priyanka Dua serve as directors at the Company.
- CIN/LLPIN
U24232CH2014PTC034943
- Company No.
034943
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jan 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Asterisk Laboratories India Private Limited offer?
Asterisk Laboratories India Private Limited offers a wide range of products and services, including Sexual Wellness Products, Fertility Enhancer, Ayurvedic Powder and Medicinal Herbs, Medicinal Plant, Ayurvedic,Herbal Products & Medicine, Ayurvedic Herbal Syrups & Tonics, Digestive System Drugs & Medicines, Antacid Drugs, Pain Relief Drugs & Pharmaceuticals, Muscle Relaxant.
Who are the key members and board of directors at Asterisk Laboratories India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashwani Mehta  | Director | 28-Jan-2014 | Current |
| Priyanka Dua | Director | 14-Jan-2015 | Current |
Financial Performance of Asterisk Laboratories India.
Asterisk Laboratories India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 21.45% decrease. The company also saw a substantial fall in profitability, with a 84.67% decrease in profit. The company's net worth moved up by a moderate rise of 1.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Asterisk Laboratories India?
Unlock access to Asterisk Laboratories India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sap Biotech India Private LimitedActive 10 years 4 monthsAshwani Mehta and Priyanka Dua are mutual person
Gracia Lifesciences India Private LimitedActive 12 years 4 monthsAshwani Mehta and Priyanka Dua are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 04 Mar 2022 | ₹2.00 Cr | Open |
Hdfc Bank Limited Creation Date: 28 May 2019 | ₹2.50 M | Open |
How Many Employees Work at Asterisk Laboratories India?
Unlock and access historical data on people associated with Asterisk Laboratories India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Asterisk Laboratories India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Asterisk Laboratories India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
